Novel CAR-T shows ‘promising early signs of clinical efficacy’ for diffuse midline gliomas

[davidfinn]

Three of four patients who received an investigational chimeric antigen receptor T-cell therapy for diffuse midline glioma showed tumor regression and...

[boray]

Hi Al & all,

Froceth in Vilnius and IOZK in Cologne are two immunotherapy centres that offer (among other modes of immuno-oncological...

[boray]

Northwest Biotherapeutics is beginning to open the UK Specials Program to new patients, at a cost of treatment greater than GBP 300k. Below is a note...

[Narwhal77]

I saw the article in Nature that was posted on the news section on this site the other day. I've read about vaccines like this and notice that they specifically...